{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T17:23:32Z","timestamp":1700587412178},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:00:00Z","timestamp":1204588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s12185-008-0053-z","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T12:04:25Z","timestamp":1204545865000},"page":"434-439","source":"Crossref","is-referenced-by-count":5,"title":["Virus reactivation in high-risk non-Hodgkin\u2019s lymphoma patients after autologous CD34+-selected peripheral blood progenitor cell transplantation"],"prefix":"10.1007","volume":"87","author":[{"given":"Peng-Chan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Tsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Tsai","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeon-Jye","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,4]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1200\/JCO.1990.8.1.84","volume":"8","author":"MA Shipp","year":"1990","unstructured":"Shipp MA, Yeap BY, Harrington DP, et al. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol. 1990;8:84\u201393.","journal-title":"J Clin Oncol."},{"key":"53_CR2","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1200\/JCO.1989.7.8.1018","volume":"7","author":"B Coiffier","year":"1989","unstructured":"Coiffier B, Gisselbrecht C, Herbrecht R, et al. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol. 1989;7:1018\u201326.","journal-title":"J Clin Oncol."},{"key":"53_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;328:1002\u20136.","journal-title":"N Engl J Med."},{"key":"53_CR4","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1995;333:1540\u20135.","journal-title":"N Engl J Med."},{"key":"53_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","year":"1993","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987\u201394.","journal-title":"N Engl J Med."},{"key":"53_CR6","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1200\/JCO.1994.12.12.2543","volume":"12","author":"C Haioun","year":"1994","unstructured":"Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin\u2019s lymphoma in first complete remission: a study of 464 patients. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 1994;12:2543\u201351.","journal-title":"J Clin Oncol."},{"key":"53_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1200\/JCO.1997.15.3.1131","volume":"15","author":"C Haioun","year":"1997","unstructured":"Haioun C, Lepage E, Gisselbrecht C, et al. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin\u2019s lymphoma: updated results of the prospective study LNH87\u20132. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte. J Clin Oncol. 1997;15:1131\u20137.","journal-title":"J Clin Oncol."},{"key":"53_CR8","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","volume":"336","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Bregni M, Siena S, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med. 1997;336:1290\u20137.","journal-title":"N Engl J Med."},{"key":"53_CR9","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.1998.16.8.2796","volume":"16","author":"G Santini","year":"1998","unstructured":"Santini G, Salvagno L, Leoni P, et al. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin\u2019s lymphoma: results of a prospective randomized trial by the non-Hodgkin\u2019s Lymphoma Cooperative Study Group. J Clin Oncol. 1998;16:2796\u2013802.","journal-title":"J Clin Oncol."},{"key":"53_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet. 1993;341:85\u20136.","journal-title":"Lancet."},{"key":"53_CR11","first-page":"3417","volume":"55","author":"M Mori","year":"1995","unstructured":"Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417\u201320.","journal-title":"Cancer Res."},{"key":"53_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/sj.bmt.1700981","volume":"20","author":"D Nachbaur","year":"1997","unstructured":"Nachbaur D, Fink FM, Nussbaumer W, et al. CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience. Bone Marrow Transplant. 1997;20:827\u201334.","journal-title":"Bone Marrow Transplant."},{"key":"53_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1046\/j.1365-2141.1998.00572.x","volume":"100","author":"T Miyamoto","year":"1998","unstructured":"Miyamoto T, Gondo H, Miyoshi Y, et al. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin\u2019s lymphoma. Br J Haematol. 1998;100:348\u201350.","journal-title":"Br J Haematol."},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","volume":"94","author":"LA Holmberg","year":"1999","unstructured":"Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 1999;94:4029\u201335.","journal-title":"Blood."},{"key":"53_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/bbmt.2002.v8.pm12064366","volume":"8","author":"F Crippa","year":"2002","unstructured":"Crippa F, Holmberg L, Carter RA, et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2002;8:281\u20139.","journal-title":"Biol Blood Marrow Transplant."},{"key":"53_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1600-0609.2005.00569.x","volume":"76","author":"P Frere","year":"2006","unstructured":"Frere P, Pereira M, Fillet G, et al. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. Eur J Haematol. 2006;76:102\u20138.","journal-title":"Eur J Haematol."},{"key":"53_CR17","first-page":"691","volume":"17","author":"H Goldschmidt","year":"1996","unstructured":"Goldschmidt H, Hegenbart U, Haas R, et al. Mobilization of peripheral blood progenitor cells with high-dose cyclophosphamide (4 or 7 g\/m2) and granulocyte colony-stimulating factor in patients with multiple myeloma. Bone Marrow Transplant. 1996;17:691\u20137.","journal-title":"Bone Marrow Transplant."},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood.V77.7.1587.1587","volume":"77","author":"T Philip","year":"1991","unstructured":"Philip T, Chauvin F, Armitage J, et al. Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood. 1991;77:1587\u201392.","journal-title":"Blood."},{"key":"53_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/sj.bmt.1704819","volume":"35","author":"Y Imai","year":"2005","unstructured":"Imai Y, Chou T, Tobinai K, et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin\u2019s lymphoma (NHL): results of Japanese phase II study. Bone Marrow Transplant. 2005;35:479\u201387.","journal-title":"Bone Marrow Transplant."},{"key":"53_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/152581600419242","volume":"9","author":"D Despres","year":"2000","unstructured":"Despres D, Flohr T, Uppenkamp M, et al. CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device. J Hematother Stem Cell Res. 2000;9:557\u201364.","journal-title":"J Hematother Stem Cell Res."},{"key":"53_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2141.2004.05062.x","volume":"126","author":"M Ringhoffer","year":"2004","unstructured":"Ringhoffer M, Wiesneth M, Harsdorf S, et al. CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients. Br J Haematol. 2004;126:527\u201335.","journal-title":"Br J Haematol."},{"key":"53_CR22","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood.V99.7.2324","volume":"99","author":"GK Lau","year":"2002","unstructured":"Lau GK, Leung YH, Fong DY, et al. High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood. 2002;99:2324\u201330.","journal-title":"Blood."},{"key":"53_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1532\/IJH97.A10411","volume":"81","author":"PC Lin","year":"2005","unstructured":"Lin PC, Poh SB, Lee MY, et al. Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients. Int J Hematol. 2005;81:349\u201351.","journal-title":"Int J Hematol."},{"key":"53_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbmt.2005.09.001","volume":"12","author":"LT Hsiao","year":"2006","unstructured":"Hsiao LT, Chiou TJ, Liu JH, et al. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2006;12:84\u201394.","journal-title":"Biol Blood Marrow Transplant."},{"key":"53_CR25","first-page":"193","volume":"70","author":"M Takeshima","year":"1999","unstructured":"Takeshima M, Takamatsu H, Iida M, et al. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation. Int J Hematol. 1999;70:193\u20139.","journal-title":"Int J Hematol."},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1182\/blood.V89.10.3873","volume":"89","author":"P Reusser","year":"1997","unstructured":"Reusser P, Attenhofer R, Hebart H, et al. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood. 1997;89:3873\u20139.","journal-title":"Blood."},{"key":"53_CR27","first-page":"215","volume":"10","author":"T Teshima","year":"1992","unstructured":"Teshima T, Harada M, Takamatsu Y, et al. Cytotoxic drug and cytotoxic drug\/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant. 1992;10:215\u201320.","journal-title":"Bone Marrow Transplant."},{"key":"53_CR28","first-page":"387","volume":"15","author":"B Hertenstein","year":"1995","unstructured":"Hertenstein B, Hampl W, Bunjes D, et al. In vivo\/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplant. 1995;15:387\u201393.","journal-title":"Bone Marrow Transplant."},{"key":"53_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1387\/ijdb.041947el","volume":"49","author":"E Landais","year":"2005","unstructured":"Landais E, Saulquin X, Houssaint E. The human T cell immune response to Epstein\u2013Barr virus. Int J Dev Biol. 2005;49:285\u2013292.","journal-title":"Int J Dev Biol."},{"issue":"7","key":"53_CR30","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood. 2007;110(7):2316\u201323. Epub 2007.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-008-0053-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0053-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-008-0053-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T13:46:16Z","timestamp":1588427176000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-008-0053-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s12185-008-0053-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,4]]}}}